FIELD: biotechnology.
SUBSTANCE: method for production of an optimized solid gene-activated material is described, comprising creation of a carrier matrix that binds at least one nucleic acid molecule, followed by placing at least one additional nucleic acid molecule on its surface by any physical method allowing such placement without chemical bond formation between the said carrier matrix and the additional nucleic acid. Also a process for preparation of a solid carrier matrix used in the method described and intended for binding of at least one nucleic acid molecule, comprising introduction of any complexing agent into the solid matrix carrier at the stage of its synthesis by treating the initial material with a solution containing a metal-complexing agent salt capable of binding of at least one nucleic acid molecule is provided. Products obtained by these methods are presented as well.
EFFECT: invention allows to receive optimized osteoplastic materials having an accurate dose of nucleic acids, more efficient dynamics of gene structures release from carrier matrix structure and increased level of recipient bed cells transfection by the biologically active substance.
5 cl, 5 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CREATING PERSONALIZED GENE-ACTIVATED IMPLANT FOR BONE TISSUE REGENERATION | 2015 |
|
RU2597786C2 |
BIOCOMPOSITE FOR PERFORMING REPARATIVE PROCESSES FOLLOWING INJURIES IN MAMMALS, METHODS FOR PREPARING (VERSIONS) AND USING SAME | 2011 |
|
RU2519326C2 |
OPTIMIZED NUCLEOTIDE SEQUENCE AND PHARMACEUTICAL COMPOSITIONS BASED THEREON WITH SUSTAINED VEGF TRANSGENE EXPRESSION | 2015 |
|
RU2612497C2 |
METHOD OF PRODUCING CERAMIC GRANULES FOR BONE TISSUE REGENERATION | 2018 |
|
RU2695342C1 |
METHOD FOR REPARATIVE ANGIOGENESIS STIMULATION AND CONNECTIVE TISSUE REGENERATION IN CASE OF ITS DAMAGE, BY THE GENETIC THERAPY METHOD USING SPECIES-SPECIFIC VEGF AND FGF2 PROTEIN FACTORS GENES IN VETERINARY MEDICINE, AND GENETIC STRUCTURE FOR IMPLEMENTATION OF METHOD | 2015 |
|
RU2614665C1 |
METHOD OF STIMULATING REPARATIVE ANGIOGENESIS AND REGENERATION OF SKIN OF DOGS WITH DAMAGE THEREOF BY GENE THERAPY USING SPECIES-SPECIFIC GENES OF PROTEIN FACTORS VEGF AND FGF2 IN VETERINARY SCIENCE AND GENETIC CONSTRUCT FOR REALIZING DECLARED METHOD | 2019 |
|
RU2719513C1 |
CARRIER FOR TARGETED DELIVERY OF NUCLEIC ACIDS TO CELLS EXPRESSING RECEPTOR CXCR4 | 2012 |
|
RU2522810C1 |
METHOD OF PRODUCING PLASMID DNA IN POLYMER NANOSPHERES FOR DELIVERY | 2022 |
|
RU2817116C1 |
METHOD FOR PREPARING A CELL-MEDIATED GENE THERAPY AGENT AND A CELL-MEDIATED GENE THERAPY AGENT | 2019 |
|
RU2716013C2 |
RECOMBINANT GENE ENCODING HBD-EPO PROTEIN, RECOMBINANT PLASMID DNA PL610, METHOD FOR PRODUCING A RECOMBINANT HBD-EPO PROTEIN, A RECOMBINANT HBD-EPO PROTEIN, A COMPOSITION FOR SPECIFICALLY INDUCING BONE REGENERATION, METHOD OF SPECIFIC INDUCTION OF BONE TISSUE REGENERATION | 2017 |
|
RU2664192C1 |
Authors
Dates
2017-06-22—Published
2016-10-07—Filed